Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.91B |
| 2 |
SPCX
SpaceX
SPCX
|
+$871M |
| 3 |
Eli Lilly
LLY
|
+$719M |
| 4 |
Amazon
AMZN
|
+$698M |
| 5 |
Netflix
NFLX
|
+$627M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$3B |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.42B |
| 4 |
NVIDIA
NVDA
|
+$1.41B |
| 5 |
SNDK
Sandisk
SNDK
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.67% |
| 2 | Technology | 3.92% |
| 3 | Healthcare | 2.55% |
| 4 | Industrials | 2.24% |
| 5 | Financials | 2.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JBIO
2501
Jade Biosciences
JBIO
$1.09B
| $20.7M | ﹤0.01% |
929,407
+792,185
| +577% | +$16.5M |
|
2502
PUT
Entegris
ENTG
$20.6B
| $20.6M | ﹤0.01% |
114,800
+38,900
| +51% | +$5.61M |
|
2503
Eastman Chemical
EMN
$7.57B
| $20.6M | ﹤0.01% |
308,256
+66,501
| +28% | +$4.86M |
|
2504
Moderna
MRNA
$63.1B
| $20.6M | ﹤0.01% |
294,496
-195,274
| -40% | -$10.1M |
|
2505
CGI
GIB
$14.7B
| $20.6M | ﹤0.01% |
319,041
+69,933
| +28% | +$4.77M |
|
2506
CALL
CDW
CDW
$18.7B
| $20.6M | ﹤0.01% |
146,300
+63,200
| +76% | +$7.94M |
|
2507
CALL
AerCap
AER
$22.5B
| $20.6M | ﹤0.01% |
141,000
-160,500
| -53% | -$22.8M |
|
|
TXNM
2508
TXNM Energy Inc
TXNM
$6.04B
| $20.6M | ﹤0.01% |
362,001
+69,010
| +24% | +$4.05M |
|
2509
Lloyds Banking Group
LYG
$85.8B
| $20.5M | ﹤0.01% |
3,524,847
+2,964,015
| +529% | +$16.1M |
|
2510
SoFi Technologies
SOFI
$21.6B
| $20.5M | ﹤0.01% |
1,145,775
-9,901,406
| -90% | -$168M |
|
2511
CALL
Kenvue
KVUE
$34.3B
| $20.5M | ﹤0.01% |
1,073,000
-513,300
| -32% | -$9.04M |
|
2512
Nutanix
NTNX
$18.9B
| $20.5M | ﹤0.01% |
402,208
-126,044
| -24% | -$5.7M |
|
|
ARX
2513
Accelerant Holdings
ARX
$4.3B
| $20.5M | ﹤0.01% |
1,747,985
+603,779
| +53% | +$8.48M |
|
2514
UiPath
PATH
$7.17B
| $20.5M | ﹤0.01% |
1,884,306
-1,206,105
| -39% | -$12.9M |
|
2515
CALL
iShares US Technology ETF
IYW
$25.5B
| $20.5M | ﹤0.01% |
81,200
-423,900
| -84% | -$97.4M |
|
2516
PUT
Coupang
CPNG
$26B
| $20.5M | ﹤0.01% |
1,178,200
-366,100
| -24% | -$6.61M |
|
2517
Idexx Laboratories
IDXX
$39.9B
| $20.5M | ﹤0.01% |
38,846
-48,720
| -56% | -$27.3M |
|
2518
Essential Properties Realty Trust
EPRT
$5.8B
| $20.4M | ﹤0.01% |
684,510
+487,960
| +248% | +$15.2M |
|
2519
PUT
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$1.21B
| $20.4M | ﹤0.01% |
174,300
-108,800
| -38% | -$18.5M |
|
2520
Ball Corp
BALL
$16.1B
| $20.4M | ﹤0.01% |
326,783
+61,546
| +23% | +$3.62M |
|
2521
The RealReal
REAL
$1.15B
| $20.4M | ﹤0.01% |
1,726,164
-101,549
| -6% | -$1.08M |
|
2522
H&R Block
HRB
$5.52B
| $20.3M | ﹤0.01% |
534,124
-2,649,051
| -83% | -$92.3M |
|
2523
PUT
Redwire
RDW
$2.89B
| $20.3M | ﹤0.01% |
1,662,700
+853,200
| +105% | +$11.3M |
|
2524
Carvana
CVNA
$47.4B
| $20.3M | ﹤0.01% |
308,928
+68,588
| +29% | +$4.85M |
|
2525
CALL
GSK
GSK
$102B
| $20.3M | ﹤0.01% |
387,700
-303,700
| -44% | -$16.1M |
|
Similar funds
Citadel Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Citadel Advisors held 15,445 positions worth $875B, up 41% from $618B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q2 2026 filing shows 2,573 new, 6,088 increased, 4,803 reduced and 1,873 closed positions. Its largest new stake was SpaceX: 5,129,884 shares worth $876M. The largest sale was Micron Technology, an estimated $3B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 79% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q2 2026 buy was SpaceX: 5,129,884 shares worth $876M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.91B increase.
- Citadel Advisors's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $3B.
- Citadel Advisors fully exited iShares 7-10 Year Treasury Bond ETF in Q2 2026, selling an estimated $325M.
- Citadel Advisors's ten largest holdings make up 23% of its $875B portfolio in Q2 2026.
- Citadel Advisors opened 2,573 new positions and closed 1,873 in Q2 2026.
- Citadel Advisors's portfolio value rose 41% quarter-over-quarter to $875B.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.